Dopamine beta-hydroxylase: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 29: Line 29:


{{stub}}
{{stub}}
<gallery>
File:Dopamine_beta-monooxygenase_reaction.svg|Dopamine beta-monooxygenase reaction
File:DBH_mechanism.png|DBH mechanism
File:Models_for_Oligomer_Structures_of_DBH.png|Models for Oligomer Structures of DBH
</gallery>

Latest revision as of 04:04, 18 February 2025

Dopamine beta-hydroxylase (DBH), also known as dopamine beta-monooxygenase, is an enzyme that catalyzes the conversion of dopamine to norepinephrine.

Function[edit]

DBH is a copper-containing oxygenase that exists as a tetramer with four identical subunits. It is located in the synaptic vesicles of postganglionic sympathetic neurons and in adrenal medulla, where it converts dopamine to norepinephrine. This conversion is a critical step in the sympathetic nervous system's production of norepinephrine, which plays a key role in the body's fight or flight response.

Clinical significance[edit]

Mutations in the DBH gene can lead to Dopamine beta hydroxylase deficiency, a condition characterized by a lack of norepinephrine and epinephrine in patients. Symptoms can include orthostatic hypotension, ptosis, and nasal stuffiness.

See also[edit]

References[edit]

<references />

External links[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia